Akkermansia muciniphila as a Next-Generation Probiotic in Modulating Human Metabolic Homeostasis and Disease Progression: A Role Mediated by Gut–Liver–Brain Axes?
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Appreciation of the importance of Akkermansia muciniphila is growing, and it is becoming increasingly relevant to identify preventive and/or therapeutic solutions targeting gut–liver–brain axes for multiple diseases via Akkermansia muciniphila. In recent years, Akkermansia muciniphila and its components such as outer membrane proteins and extracellular vesicles have been known to ameliorate host metabolic health and intestinal homeostasis. However, the impacts of Akkermansia muciniphila on host health and disease are complex, as both potentially beneficial and adverse effects are mediated by Akkermansia muciniphila and its derivatives, and in some cases, these effects are dependent upon the host physiology microenvironment and the forms, genotypes, and strain sources of Akkermansia muciniphila. Therefore, this review aims to summarize the current knowledge of how Akkermansia muciniphila interacts with the host and influences host metabolic homeostasis and disease progression. Details of Akkermansia muciniphila will be discussed including its biological and genetic characteristics; biological functions including anti-obesity, anti-diabetes, anti-metabolic-syndrome, anti-inflammation, anti-aging, anti-neurodegenerative disease, and anti-cancer therapy functions; and strategies to elevate its abundance. Key events will be referred to in some specific disease states, and this knowledge should facilitate the identification of Akkermansia muciniphila-based probiotic therapy targeting multiple diseases via gut–liver–brain axes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724 · cited 1×
“Atherosclerosis (AS) is the main contributor to cardiovascular mortality [83].”
BackgroundA metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671 · cited 4×
“, adipose and muscle) axes [22], as well as cancer therapy [151].”
BackgroundMethodInfluentialGut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · cited 1×
“Metabolomics analysis indicated that the gut microbiota producing proatherogenic trimethylamine-N-oxide (TMAO) after being fed phosphatidylcholine can accelerate AS in mice [84].”
BackgroundObesity: global epidemiology and pathogenesis
Blüher, M. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0176-8 · Cited by 5,126 · cited 2×
“Obesity and T2D are associated with low-grade inflammation and specific changes in gut microbiota composition such as Akk prevalence [22,44].”
BackgroundRichness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
The impact of the gut microbiota on human health: an integrative view
Clemente, J. C., Ursell, L. K., Parfrey, L. W., & Knight, R. (2012) · Cell · doi:10.1016/j.cell.2012.01.035 · Cited by 3,710 · cited 5×
“Abbreviations: ALD: alcoholic liver disease; ASH: alcoholic steatohepatitis; NAFLD: non-alcoholic fatty liver disease; NASH: nonalcoholic steatohepatitis; HCC: hepatocellular carcinoma; WD: Western diet; HFD: high-fat diet; HFHC: high-fat high-cholesterol; TLRs: Toll-like receptors; LPS: lipopolysaccharide; TG: trigly…”
BackgroundInfluentialIntroduction to the human gut microbiota
Thursby, E., & Juge, N. (2017) · Biochemical Journal · doi:10.1042/bcj20160510 · Cited by 3,600
Depommier, C., Everard, A., Druart, C., Plovier, H., Van Hul, M., Vieira-Silva, S., Falony, G., Raes, J., Maiter, D., Delzenne, N. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0495-2 · Cited by 2,357
Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., Chilloux, J., Ottman, N., Duparc, T., Lichtenstein, L., et al. (2017) · Nature Medicine · doi:10.1038/nm.4236 · Cited by 2,204 · cited 17×
“In addition to the live bacteria of Akk and its metabolites, the pasteurization of Akk also equally reduces fat mass development, IR, and dyslipidemia in mice compared with the unpasteurized bacterium [22].”
BackgroundInfluentialObesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., et al. (2015) · Nature · doi:10.1038/nature15766 · Cited by 2,116
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.02873-0 · Cited by 2,094 · cited 6×
“As one representative of mucus-degrading bacteria, Akk specializes in the utilization of mucin as a carbon and nitrogen source and efficiently colonizes the colon, which produces most of the mucins and is closely associated with the intestinal cells [4,161].”
BackgroundInfluentialDietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
Chassaing, B., Koren, O., Goodrich, J. K., Poole, A. C., Srinivasan, S., Ley, R. E., & Gewirtz, A. T. (2015) · Nature · doi:10.1038/nature14232 · Cited by 2,055 · cited 1×
“Administration in IL10−/− mice of two commonly used food emulsifiers, carboxymethylcellulose (CMC) or polysorbate-80 (P80), both reduced microbial diversity, but, in particular, promoted the abundance of Akk, colitis, and metabolic syndrome, which may have triggered an excessive immune response, thereby disrupting muc…”
BackgroundReciprocal interactions of the intestinal microbiota and immune system
Maynard, C. L., Elson, C. O., Hatton, R. D., & Weaver, C. T. (2012) · Nature · doi:10.1038/nature11551 · Cited by 1,598 · cited 1×
“The intestinal barrier consists of a mechanical barrier, chemical barrier, immune barrier, and biological barrier, which prevent pathogens and toxins from entering the body through the intestinal mucosa [157,158].”
BackgroundPng, C. W., Lindén, S. K., Gilshenan, K. S., Zoetendal, E. G., McSweeney, C. S., Sly, L. I., McGuckin, M. A., & Florin, T. H. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.281 · Cited by 1,364 · cited 1×
“In the last decade especially, it was uncovered that Akk can prevent and ameliorate obesity [12], diabetes [13], metabolic syndrome [14], inflammation [15], aging [16,17], negative effects of cancer therapy [18], neurodegenerative diseases [19], etc.”
BackgroundAkkermansia muciniphila: paradigm for next-generation beneficial microorganisms
Cani, P. D., Depommier, C., Derrien, M., Everard, A., & de Vos, W. M. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00631-9 · Cited by 1,192
Anhê, F. F., Roy, D., Pilon, G., Dudonné, S., Matamoros, S., Varin, T. V., Garofalo, C., Moine, Q., Desjardins, Y., Levy, E., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307142 · Cited by 1,137
Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila
Cani, P. D., & de Vos, W. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01765 · Cited by 1,058
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet
Olson, C. A., Vuong, H. E., Yano, J. M., Liang, Q. Y., Nusbaum, D. J., & Hsiao, E. Y. (2018) · Cell · doi:10.1016/j.cell.2018.04.027 · Cited by 1,057 · cited 3×
“Antibiotic treatment or germ-free rearing depletes the KD-mediated seizure protection function in mice, whereas enrichment of, and gnotobiotic co-colonization with, KD-associated Akk and Parabacteroides restores seizure protection [154].”
BackgroundInfluentialFloegel, A., Stefan, N., Yu, Z., Mühlenbruch, K., Drogan, D., Joost, H.-G., Fritsche, A., Häring, H.-U., Hrabě de Angelis, M., Peters, A., et al. (2013) · Diabetes · doi:10.2337/db12-0495 · Cited by 988
Levy, M., Thaiss, C. A., Zeevi, D., Dohnalová, L., Zilberman-Schapira, G., Mahdi, J. A., David, E., Savidor, A., Korem, T., Herzig, Y., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.048 · Cited by 960
Caesar, R., Tremaroli, V., Kovatcheva-Datchary, P., Cani, P. D., & Bäckhed, F. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.026 · Cited by 960 · cited 1×
“Compared with lard, mice fed fish oil for 11 weeks (dietary lipid-enriched omega-3 polyunsaturated fatty acid) demonstrated significantly increased abundance of Akk and Lactobacillus in their cecal contents [184].”
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., et al. (2017) · Scientific Reports · doi:10.1038/srep41802 · Cited by 901
Li, J., Lin, S., Vanhoutte, P. M., Woo, C. W., & Xu, A. (2016) · Circulation · doi:10.1161/circulationaha.115.019645 · Cited by 775 · cited 5×
“As explained above, Akk can ameliorate gut barrier impairment in the cases of obesity [22,39,40,47], metabolic diseases [71,76,85], inflammation [85,122,123], and aging [125,129–132]; therefore, it is necessary to know how”
BackgroundInfluentialIntestinal microbiota in human health and disease: the impact of probiotics
Gerritsen, J., Smidt, H., Rijkers, G. T., & de Vos, W. M. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0229-7 · Cited by 724 · cited 1×
“The gut microbiota is the key regulator of host homeostasis and the compositional imbalance of microbial communities commonly causes metabolic disorders and exacerbates disease progression [7].”
BackgroundAkkermansia muciniphila is a promising probiotic
Zhang, T., Li, Q., Cheng, L., Buch, H., & Zhang, F. (2019) · Microbial Biotechnology · doi:10.1111/1751-7915.13410 · Cited by 708
Collado, M. C., Derrien, M., Isolauri, E., de Vos, W. M., & Salminen, S. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01477-07 · Cited by 706
de la Cuesta-Zuluaga, J., Mueller, N. T., Corrales-Agudelo, V., Velásquez-Mejía, E. P., Carmona, J. A., Abad, J. M., & Escobar, J. S. (2017) · Diabetes Care · doi:10.2337/dc16-1324 · Cited by 704 · cited 1×
“Metformin, the most popular first-line drug for the treatment of T2D, can ameliorate gut microbiota composition through an increased abundance of Akk, as well as several SCFA-producing microbiotas [169,183].”
BackgroundPotential roles of gut microbiome and metabolites in modulating ALS in mice
Blacher, E., Bashiardes, S., Shapiro, H., Rothschild, D., Mor, U., Dori-Bachash, M., Kleimeyer, C., Moresi, C., Harnik, Y., Zur, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1443-5 · Cited by 700 · cited 9×
“Akk treatment increases nicotinamide in the CNS, and systemic supplementation of nicotinamide also promotes motor symptoms and gene expression patterns in ALS mice, which is further evidenced by reduced levels of nicotinamide systemically and in the cerebrospinal fluid in human ALS patients [148].”
BackgroundInfluentialDerosa, L., Routy, B., Thomas, A. M., Iebba, V., Zalcman, G., Friard, S., Mazieres, J., Audigier-Valette, C., Moro-Sibilot, D., Goldwasser, F., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01655-5 · Cited by 685 · cited 10×
“FMT from patients with NSCLC who respond to ICIs in germ-free or antibiotic-treated mice ameliorates the antitumor effect of PD-1 blockade, whereas FMT from nonresponding patients fails to do so, which is correlated with the relative abundance of Akk [151].”
BackgroundMethodInfluentialDiets that differ in their FODMAP content alter the colonic luminal microenvironment
Halmos, E. P., Christophersen, C. T., Bird, A. R., Shepherd, S. J., Gibson, P. R., & Muir, J. G. (2015) · Gut · doi:10.1136/gutjnl-2014-307264 · Cited by 681
Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice
Bárcena, C., Valdés-Mas, R., Mayoral, P., Garabaya, C., Durand, S., Rodríguez, F., Fernández-García, M. T., Salazar, N., Nogacka, A. M., Garatachea, N., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0504-5 · Cited by 661 · cited 3×
“Consistent with human progeria patients, the abundance of Proteobacteria and Cyanobacteria are increased but Verrucomicrobia is decreased in both LmnaG609G/G609G mice and Zmpste24−/− mouse models, whereas long-lived humans (that is, centenarians) exhibit a substantial increase in Verrucomicrobia and Proteobacteria red…”
BackgroundRhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44442 · Cited by 647
Wang, L., Tang, L., Feng, Y., Zhao, S., Han, M., Zhang, C., Yuan, G., Zhu, J., Cao, S., Wu, Q., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320105 · Cited by 630 · cited 8×
“Akk also decreases the frequency of activated CD80+CD273-B cells in Peyer’s patches and Ly6Cint monocyte frequencies in the spleen and MLNs but increases the number of peritoneal resident macrophages [16].”
BackgroundInfluentialRecovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease
Grander, C., Adolph, T. E., Wieser, V., Lowe, P., Wrzosek, L., Gyongyosi, B., Ward, D. V., Grabherr, F., Gerner, R. R., Pfister, A., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313432 · Cited by 618 · cited 3×
“As explained above, Akk can ameliorate gut barrier impairment in the cases of obesity [22,39,40,47], metabolic diseases [71,76,85], inflammation [85,122,123], and aging [125,129–132]; therefore, it is necessary to know how”
BackgroundAkkermansia muciniphila induces intestinal adaptive immune responses during homeostasis
Ansaldo, E., Slayden, L. C., Ching, K. L., Koch, M. A., Wolf, N. K., Plichta, D. R., Brown, E. M., Graham, D. B., Xavier, R. J., Moon, J. J., et al. (2019) · Science · doi:10.1126/science.aaw7479 · Cited by 566 · cited 2×
“However, a recent study reported that Akk-induced intestinal adaptive T cell immune responses were only limited to T follicular helper (TFH) cells in a gnotobiotic setting during homeostasis [111].”
BackgroundMucin-bacterial interactions in the human oral cavity and digestive tract
Derrien, M., van Passel, M. W. J., van de Bovenkamp, J. H. B., Schipper, R., de Vos, W., & Dekker, J. (2010) · Gut Microbes · doi:10.4161/gmic.1.4.12778 · Cited by 556 · cited 1×
“Patients with IBD and mice with colitis or colitis-associated colorectal cancer (CAC) display a significant reduction in Akk compared to the healthy control group [99,100].”
BackgroundKang, C.-S., Ban, M., Choi, E.-J., Moon, H.-G., Jeon, J.-S., Kim, D.-K., Park, S.-K., Jeon, S. G., Roh, T.-Y., Myung, S.-J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076520 · Cited by 543 · cited 14×
“TLR4 knockout exacerbated DSS-induced colitis of TLR4−/− mice mediated by gut microbiota and the abundance of Akk was significantly decreased in TLR4−/− mice, whereas it was enriched in wild-type mice [108].”
BackgroundInfluentialGanesh, B. P., Klopfleisch, R., Loh, G., & Blaut, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074963 · Cited by 522 · cited 12×
“TLR4 knockout exacerbated DSS-induced colitis of TLR4−/− mice mediated by gut microbiota and the abundance of Akk was significantly decreased in TLR4−/− mice, whereas it was enriched in wild-type mice [108].”
BackgroundInfluentialMACFABE, D., CAIN, D., RODRIGUEZCAPOTE, K., FRANKLIN, A., HOFFMAN, J., BOON, F., TAYLOR, A., KAVALIERS, M., & OSSENKOPP, K. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.025 · Cited by 497 · cited 5×
“The abundance of Akk is decreased in children with autism/ASD, whereas it is increased in patients with PD.”
BackgroundInfluentialWang, L., Christophersen, C. T., Sorich, M. J., Gerber, J. P., Angley, M. T., & Conlon, M. A. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05212-11 · Cited by 432 · cited 1×
“Children with autism show a lower relative abundance of Akk in fecal matter, which is associated with a change in mucus barrier [143].”
BackgroundXu, Y., Wang, N., Tan, H.-Y., Li, S., Zhang, C., & Feng, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00219 · Cited by 420 · cited 1×
“In the last decade especially, it was uncovered that Akk can prevent and ameliorate obesity [12], diabetes [13], metabolic syndrome [14], inflammation [15], aging [16,17], negative effects of cancer therapy [18], neurodegenerative diseases [19], etc.”
BackgroundAkkermansia muciniphila phospholipid induces homeostatic immune responses
Bae, M., Cassilly, C. D., Liu, X., Park, S.-M., Tusi, B. K., Chen, X., Kwon, J., Filipčík, P., Bolze, A. S., Liu, Z., et al. (2022) · Nature · doi:10.1038/s41586-022-04985-7 · Cited by 413 · cited 4×
“This lipid is a diacyl phosphatidylethanolamine with two branched chains (a15:0-i15:0 PE) that can induce the production of TNF-α and IL-6 in DCs [109].”
BackgroundInfluentialNLRP6 Protects Il10 Mice from Colitis by Limiting Colonization of Akkermansia muciniphila
Seregin, S. S., Golovchenko, N., Schaf, B., Chen, J., Pudlo, N. A., Mitchell, J., Baxter, N. T., Zhao, L., Schloss, P. D., Martens, E. C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.080 · Cited by 386 · cited 2×
“In both specific pathogenfree and germ-free IL-10−/− mice, the colonization of Akk mediated by NLRP6 was enough to promote intestinal inflammation by inhibiting IL-18 production after modulating the abundance of Akk [122,123].”
BackgroundMeta‐Analysis of Gut Dysbiosis in Parkinson's Disease
Nishiwaki, H., Ito, M., Ishida, T., Hamaguchi, T., Maeda, T., Kashihara, K., Tsuboi, Y., Ueyama, J., Shimamura, T., Mori, H., et al. (2020) · Movement Disorders · doi:10.1002/mds.28119 · Cited by 370
Zhai, R., Xue, X., Zhang, L., Yang, X., Zhao, L., & Zhang, C. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00239 · Cited by 368
Hänninen, A., Toivonen, R., Pöysti, S., Belzer, C., Plovier, H., Ouwerkerk, J. P., Emani, R., Cani, P. D., & De Vos, W. M. (2018) · Gut · doi:10.1136/gutjnl-2017-314508 · Cited by 359
Ou, Z., Deng, L., Lu, Z., Wu, F., Liu, W., Huang, D., & Peng, Y. (2020) · Nutrition & Diabetes · doi:10.1038/s41387-020-0115-8 · Cited by 328 · cited 1×
“In the last decade especially, it was uncovered that Akk can prevent and ameliorate obesity [12], diabetes [13], metabolic syndrome [14], inflammation [15], aging [16,17], negative effects of cancer therapy [18], neurodegenerative diseases [19], etc.”
BackgroundAkkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice
Zhao, S., Liu, W., Wang, J., Shi, J., Sun, Y., Wang, W., Ning, G., Liu, R., & Hong, J. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0054 · Cited by 298 · cited 3×
“Lean chow diet-fed mice supplementation with Akk significantly suppresses obesity and associated metabolic profiles and endoplasmic reticulum (ER) stress in the liver and muscle [48].”
BackgroundShang, Q., Song, G., Zhang, M., Shi, J., Xu, C., Hao, J., Li, G., & Yu, G. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2016.11.002 · Cited by 258
Schneider, K. M., Mohs, A., Gui, W., Galvez, E. J. C., Candels, L. S., Hoenicke, L., Muthukumarasamy, U., Holland, C. H., Elfers, C., Kilic, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31312-5 · Cited by 225 · cited 6×
“As previously mentioned, the relative abundance of Akk is reduced in HCC model mice, and continuous treatment with Akk restores the diversity of gut microbiota and reduces liver injury, inflammation, and fibrosis [82].”
BackgroundInfluentialvan der Lugt, B., van Beek, A. A., Aalvink, S., Meijer, B., Sovran, B., Vermeij, W. P., Brandt, R. M. C., de Vos, W. M., Savelkoul, H. F. J., Steegenga, W. T., et al. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0145-z · Cited by 217
Adipose tissue, obesity and non-alcoholic fatty liver disease
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2017) · Minerva Endocrinology · doi:10.23736/s0391-1977.16.02563-3 · Cited by 207
Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells
Bodogai, M., O’Connell, J., Kim, K., Kim, Y., Moritoh, K., Chen, C., Gusev, F., Vaughan, K., Shulzhenko, N., Mattison, J. A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat4271 · Cited by 182 · cited 1×
“Aging is a major risk factor for the development of many diseases including cancer [127], chronic inflammation [128], GI disorder [129], and metabolic diseases [130].”
BackgroundDaisley, B. A., Chanyi, R. M., Abdur-Rashid, K., Al, K. F., Gibbons, S., Chmiel, J. A., Wilcox, H., Reid, G., Anderson, A., Dewar, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18649-5 · Cited by 128
Genotypic and Phenotypic Diversity among Human Isolates of Akkermansia muciniphila
Becken, B., Davey, L., Middleton, D. R., Mueller, K. D., Sharma, A., Holmes, Z. C., Dallow, E., Remick, B., Barton, G. M., David, L. A., et al. (2021) · mBio · doi:10.1128/mbio.00478-21 · Cited by 125 · cited 1×
“Genomic and phenotypic analysis of 71 new Akk strains from a cohort of children and adolescents undergoing obesity treatment revealed the genotypic and phenotypic diversity of Akk and some phylogroupspecific traits such as oxygen tolerance, adherence, and sulfur acquisition, which likely influence the colonization of…”
BackgroundOuyang, J., Lin, J., Isnard, S., Fombuena, B., Peng, X., Marette, A., Routy, B., Messaoudene, M., Chen, Y., & Routy, J.-P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00645 · Cited by 124 · cited 1×
“A recent review elaborated on Akk as a sentinel for gut permeability and its relevance to HIV-related inflammation, and the author suggested that gut microbiota enriched in Akk could reduce microbial translocation and inflammation, lower the risk of developing non-AIDS comorbidities, and improve quality of life in peo…”
BackgroundFabbri, E., Chia, C. W., Spencer, R. G., Fishbein, K. W., Reiter, D. A., Cameron, D., Zane, A. C., Moore, Z. A., Gonzalez-Freire, M., Zoli, M., et al. (2017) · Diabetes · doi:10.2337/db16-0754 · Cited by 76 · cited 2×
“Aging is commonly associated with chronic inflammation, which also is the main hallmark and risk factor of hyperglycemia and IR with the development of age [128].”
BackgroundRing, C., Klopfleisch, R., Dahlke, K., Basic, M., Bleich, A., & Blaut, M. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1511663 · Cited by 52 · cited 1×
“IL-10-deficient mice (IL-10−/−) usually display chronic colitis in histology that is similar to humans with IBD [120] and while the IL-10−/− mice treatment with Akk does not promote the development of short-term intestinal inflammation, long-term supplementation of Akk has not been completely evaluated [121].”
Background
Cited by
Dumitru, C. N., Dumitru, A. O., Goroftei, L., Niculet, E., Ignat, M. D., Baroiu, L., Nechita, A., & Balan, G. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18060651 · Cited by 4
Hoisington, A. J., Stearns-Yoder, K. A., Stamper, C. E., Holliday, R., Brostow, D. P., Penzenik, M. E., Forster, J. E., Postolache, T. T., Lowry, C. A., & Brenner, L. A. (2024) · mSystems · doi:10.1128/msystems.01021-23 · Cited by 3
Metadata
- Authors
- Jian, H., Liu, Y., Wang, X., Dong, X., & Zou, X.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-02-15
- Volume
- 24
- Issue
- 4
- Pages
- 3900
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4320919870
- Cited by
- 173
- References
- 62
- FWCI
- 12.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.